CD8A and myeloid sarcoma: Interestingly, previous studies have highlighted an inverse association between the adaptive immune responses in vaccinated aCD20-MS patients, with individuals lacking anti-RBD IgG production showing a more robust CD8+ T-cell response (21, 46).